Monmouth Junction, NJ, United States of America

Guo Q Shi

This inventor holds 4 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignees: Merck + Co., Inc., Merck Sharp + Dohme Corp.. Active years: 2009-2010.


% Patents Active = 25.0



Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2009-2010

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Unveiling the Inventor: Guo Q Shi

Introduction:

Guo Q Shi, a prolific inventor based in Monmouth Junction, NJ, has made significant contributions to the field of pharmaceuticals with his innovative patented compounds. With a total of 4 patents to his name, Guo Q Shi continues to push the boundaries of science and medicine.

Latest Patents:

Guo Q Shi's latest patents showcase his expertise in developing compounds with anti-diabetic properties. The "Fused-aromatic compounds having anti-diabetic activity" and "Antidiabetic oxazolidinediones and thiazolidinediones" patents highlight his focus on PPAR gamma agonists, essential for treating type II diabetes and its associated conditions.

Career Highlights:

Having worked at renowned pharmaceutical companies like Merck & Company, Inc. and Merck Sharp & Dohme Corporation, Guo Q Shi has honed his skills and expertise in drug development. His patents stand as a testament to his dedication to improving healthcare outcomes for diabetes patients worldwide.

Collaborations:

Throughout his career, Guo Q Shi has collaborated with industry experts such as Yong Zhang and Peter T Meinke. These fruitful collaborations have not only enhanced his research capabilities but have also led to groundbreaking discoveries in the field of pharmacology.

Conclusion:

In conclusion, Guo Q Shi's innovative work in developing anti-diabetic compounds underscores his commitment to advancing the field of medicine. His patents serve as a beacon of hope for those battling type II diabetes, offering promising treatment options for a healthier future.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…